Airbus Group N.V. ADS (EADSY) Financials Nov 14, 2014, 8:10
Airbus Group N.V. ADS (EADSY) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Airbus Group N.V. ADS
Fiscal year is January-December. All values EUR millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 42.82B 45.75B 49.13B 56.48B 59.26B
Cost of Goods Sold (COGS) incl. D&A 38.38B 39.53B 42.29B 48.54B 50.76B
COGS excluding D&A 36.63B 37.1B 40.56B 46.49B 48.9B
Depreciation & Amortization Expense 1.75B 2.42B 1.72B 2.05B 1.86B
Depreciation 1.39B 2.21B 1.37B 1.62B 1.5B
Amortization of Intangibles 363M 219M 357M 431M 368M
Gross Income 4.44B 6.22B 6.84B 7.94B 8.5B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 5.02B 5.25B 5.56B 6.01B 5.83B
Research & Development 2.83B 2.94B 3.15B 3.14B 3.16B
Other SG&A 2.2B 2.31B 2.41B 2.87B 2.67B
Other Operating Expense 99M 101M 181M 209M 229M
Unusual Expense 0 349M 287M 66M 459M
EBIT after Unusual Expense 0 (349M) (287M) (66M) (459M)
Non Operating Income/Expense (264M) 247M 373M (248M) (271M)
Non-Operating Interest Income 361M 334M 405M 243M 219M
Equity in Affiliates (Pretax) - - 0 - -
Interest Expense 503M 415M 364M 250M 243M
Gross Interest Expense 503M 415M 364M 255M 255M
Interest Capitalized 0 0 0 5M 12M
Pretax Income (1.09B) 689M 1.23B 1.4B 1.68B
Income Tax (220M) 244M 356M 438M 502M
Income Tax - Current Domestic 208M 259M 253M 409M 470M
Income Tax - Current Foreign - - 0 0 0
Income Tax - Deferred Domestic (428M) (15M) 103M 29M 32M
Income Tax - Deferred Foreign - - 0 0 0
Income Tax Credits 0 - 0 0 0
Equity in Affiliates 115M 127M 164M 241M 295M
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (752M) 572M 1.04B 1.2B 1.48B
Minority Interest Expense 11M 19M 4M 1M 10M
Net Income (763M) 553M 1.03B 1.2B 1.47B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 - - 0 0
Net Income After Extraordinaries (763M) 553M 1.03B 1.2B 1.47B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (763M) 553M 1.03B 1.2B 1.47B
EPS (Basic) (0.94) 0.68 1.27 1.46 1.85
Basic Shares Outstanding 809.7M 810.69M 812.51M 819.38M 792.47M
EPS (Diluted) (0.94) 0.68 1.27 1.46 1.84
Diluted Shares Outstanding 809.7M 810.94M 813.7M 820.55M 794.13M
EBITDA 1.07B 3.3B 2.83B 3.77B 4.3B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Unlocking Global Paths for Rare Diseases Diving straight into the biotech hustle, Kos Biotechnology Partners is making waves with their latest strategic move. They've just announced a significant investment in Golden Age Health (GAH), aiming to open new doors for rare disease treatments where they're needed most. Bridging Gaps with Strategic Investment We're talking about...
Continue Reading
Shaking Up the Robotics Game: FFR's Bold Move The recent deal between FF EAI Robotics Ecosystem (FFR) and Faraday Future Intelligent Electric (FFAI) is one of those moments. You know, when a company decides to go big or go home. FFR completed the acquisition of FFAI's robotics arm, and they’ve been quick to swap stock with Smart Technology Holdings Ltd. Now, we’ve got...
Continue Reading
CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...
Continue Reading
If you're looking to invest in an education with promising payoffs, you might look into what's cooking over at Post University. They've just dropped a bombshell of new programs sure to get some attention from tech heads and health nuts alike, and I can't help but think there's potential brewing here. New Academic Paths Emerge Post University isn't resting on its...
Continue Reading
Retlaw's Big Move in the Plastics Game In the sprawling world of plastics, some might say each piece tells a story—not unlike this latest saga with Retlaw Industries, Inc. and AIM Processing. Picture Wisconsin's Retlaw, nestled in the heart of manufacturing, recently shaking hands with fellow molder AIM Processing. This isn't just a neighborly team-up; it's a power play...
Continue Reading
AVANT BIO's Latest Power Play Alright, here's a big splash in the gene pool of life sciences—AVANT BIO just drafted two industry veterans, Peggy Lio and Philip Vanek, into their Operating Advisor Hall of Fame. And these folks aren't just window dressing. They're packing experience from some of the big hitters like GE Healthcare and Lonza, ready to roll up their sleeves...
Continue Reading
Unprecedented Spotlight on Independent Voters The political landscape is in for a shake-up, folks. Come November 3rd, we're witnessing something that hasn't been done before—an entire Election Night dedicated exclusively to independent voters. It’s high time these folks got the spotlight, considering a whopping 45% of U.S. adults have shunned the extremist seesaw of...
Continue Reading
Teamsters Flex Muscles in So-Cal Sanitation Sector So here's one for the books: 700 Waste Management workers represented by Teamsters Local 396 just locked down a fresh collective bargaining agreement in Los Angeles and Orange counties. And let me tell you, this isn’t just another contract—it's a testament to what solidarity can wring out of a massive corporation. The...
Continue Reading
HIMS Investors Find Themselves in Hot Water Well, it looks like the ball's in your court, folks. Hims & Hers Health, Inc. (NYSE: HIMS) has been caught in a whirlwind of legal drama, and if you're holding any $HIMS stock, you've got some decisions to make—and fast. With a looming November 2 deadline to step up in a securities class action, this is one of those...
Continue Reading
Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...
Continue Reading
Top 5 Most Recently Viewed Articles
Transforming Healthcare with Advanced AI Solutions Kontakt.io continues to innovate in the healthcare sector by launching the Patient Flow Agent, an advanced patient flow orchestration solution designed to revolutionize the way hospitals manage their patient journeys. The initiative aligns with the company's overarching goal of fostering seamless progress in patient care...
Continue Reading
Wistron's Bold Step into U.S. Manufacturing The industrial scene just got a jolt with Wistron's $700 million splash in Fort Worth, Texas. This isn't just another plant; it's a leap into the future with its D1 AI smart facility. Wistron shooting for the stars with their NVIDIA partnership shows they're dead serious about turning the U.S. into a powerhouse in AI...
Continue Reading
GrantWatch Unveils an Innovative AI Grant Writing Tool GrantWatch has made waves in the nonprofit community with the launch of a groundbreaking AI Grant Writing Tool that is now an essential feature of every MemberPlus+ subscription. A Unique Blend of Technology and Expertise This is not just another AI product; it’s a pioneering tool that uses sophisticated language...
Continue Reading
Experience Hokusai Like Never Before Tickets are now available for the highly anticipated exhibition "HOKUSAI: ANOTHER STORY in TOKYO." This innovative immersive event will transport visitors into the captivating world of Katsushika Hokusai, renowned as one of Japan's greatest ukiyo-e masters. An Immersive Journey Through Time This exhibition is set to run from early...
Continue Reading
Marqeta Investors Reminded of Critical Class Action Marqeta, Inc. (NASDAQ: MQ) is currently facing a significant class action lawsuit that has drawn the attention of both investors and legal experts. As this situation unfolds, it's crucial for shareholders to remain informed about their rights and options moving forward. The Allegations of the Case Robbins LLP is...
Continue Reading